STOCK TITAN

FOXO Technologies Inc. Subsidiary, Myrtle Recovery Centers, Recognized by the Rural Health Association of Tennessee for Outstanding Community Impact

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

FOXO Technologies (OTC: FOXO) announced that its behavioral health subsidiary, Myrtle Recovery Centers, was recognized by the Rural Health Association of Tennessee (RHA) at the RHA Annual Conference Awards Luncheon on Dec. 9, 2025.

Myrtle was noted for ongoing community engagement and sharing lessons learned after marking two years of accepting patients in August and serving individuals from 63 of Tennessee’s 95 counties. Leadership said Myrtle operated at capacity for most of 2025 and plans to increase capacity and expand with additional facilities in coming years. Myrtle’s CEO Robert Merritt also presented on substance use disorder treatment and rural behavioral health stigma.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

%
1 alert
% News Effect

On the day this news was published, FOXO declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Counties served: 63 counties Total counties: 95 counties Working capital deficit: $27.3M +5 more
8 metrics
Counties served 63 counties Myrtle Recovery Centers patients across Tennessee
Total counties 95 counties Total Tennessee counties referenced in outreach
Working capital deficit $27.3M As of June 30, 2025 (10-Q)
Cash and equivalents $0.3M As of June 30, 2025 (10-Q)
Cash used in operations $3.7M Six months ended June 30, 2025 (10-Q)
Total debt $11.2M Net of discounts, June 30, 2025 (10-Q)
Healthcare net revenue $5.2M Three months ended June 30, 2025 (healthcare segment)
Healthcare net revenue $8.4M Six months ended June 30, 2025 (healthcare segment)

Market Reality Check

Price: $0.0001 Vol: Volume 19,672,667 vs 20-d...
low vol
$0.0001 Last Close
Volume Volume 19,672,667 vs 20-day average 77,572,209 (relative 0.25x) ahead of this announcement. low
Technical Price 0.0002 is trading below the 200-day MA of 0.89, reflecting prior severe weakness.

Peers on Argus

Peers showed mixed moves: OTRK -18.89%, BEAT +46.21%, WORX -5.24%, while others ...
2 Up

Peers showed mixed moves: OTRK -18.89%, BEAT +46.21%, WORX -5.24%, while others were flat. Momentum scanner flagged BEAT and HCTI modestly up (~4%), but FOXO’s flat price suggests this recognition news was stock-specific rather than part of a broad sector move.

Historical Context

5 past events · Latest: Dec 09 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Dec 09 Subsidiary recognition Positive +0.0% Myrtle Recovery Centers honored for statewide rural behavioral health impact.
Sep 22 Acquisition closing Positive +12.0% Closed Vector Biosource deal with detailed cash, preferred stock and warrant terms.
Sep 11 Acquisition agreement Positive -16.9% Signed purchase agreement to acquire Vector Biosource with funding commitments.
Aug 13 Delisting/OTC move Negative -91.8% NYSE American delisting and transition to OTC trading after low share price.
Aug 06 Facility acquisition plan Positive -11.6% Non-binding deal for $22M assisted-living facility and portfolio expansion plans.
Pattern Detected

Strategic acquisition announcements have often seen negative or mixed price reactions, while clearly negative listing-status news aligned with steep declines.

Recent Company History

Over the last six months, FOXO navigated major listing and acquisition changes. In August 2025, it announced a non-binding $22M assisted-living acquisition and later disclosed NYSE delisting and OTC trading, which coincided with a -91.76% reaction. Subsequent Vector Biosource acquisition steps in September 2025 produced mixed moves. Today’s RHA recognition for Myrtle Recovery Centers highlights operational impact in behavioral health, complementing earlier expansion efforts rather than shifting the financial picture.

Market Pulse Summary

This announcement highlights Myrtle Recovery Centers’ recognized impact across 63 of Tennessee’s 95 ...
Analysis

This announcement highlights Myrtle Recovery Centers’ recognized impact across 63 of Tennessee’s 95 counties and sustained operation at capacity during 2025, reinforcing FOXO’s behavioral health footprint. In context, FOXO’s recent filings show a working capital deficit of $27.3M, cash of $0.3M, and debt of $11.2M, alongside growing healthcare revenues. Investors monitoring this story may focus on how such operational wins translate into improved liquidity, profitability, and execution of expansion plans.

Key Terms

behavioral health, substance use disorder
2 terms
behavioral health medical
"its behavioral health subsidiary, Myrtle Recovery Centers, Inc., was recently recognized"
Behavioral health covers services, treatments and products that address mental health, substance use and other behavior-related conditions—everything from therapy and counseling to addiction treatment, psychiatric care and digital mental-health apps. Investors care because demand, reimbursement rules, regulation and the effectiveness of treatments directly affect revenue and costs for providers and companies, much like how advances or policy changes in any essential service can change who buys it and how profitable it is.
substance use disorder medical
"delivering an educational session on substance use disorder treatment, behavioral health"
A substance use disorder is a chronic health condition where a person loses control over using drugs or alcohol despite negative consequences, similar to a car whose brakes fail and keeps accelerating toward harm. For investors, it matters because it drives demand for treatments, affects healthcare costs and insurance claims, influences workforce productivity, and can create regulatory, legal or market risks and opportunities for companies developing therapies, treatment services, or related products.

AI-generated analysis. Not financial advice.

WEST PALM BEACH, FL, Dec. 09, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., was recently recognized by the Rural Health Association of Tennessee (“RHA”) at their Awards Luncheon during the Annual RHA Conference.

RHA celebrated Myrtle’s ongoing engagement, willingness to share lessons learned, and its service to communities across Tennessee. The recognition comes after Myrtle celebrated two years of accepting patients in August marked by serving individuals from 63 of Tennessee’s 95 counties reflecting the statewide need for accessible, recovery-focused care.

“This acknowledgment from RHA is deeply meaningful to our team,” said Robert Merritt, MSN, RN, Chief Executive Officer of Myrtle Recovery Centers. “It reinforces the importance of expanding access to treatment in rural communities and is evidence of the results we are achieving with our treatment plan at Myrtle. We have been operating at capacity now for most of 2025 and look forward to increasing our capacity and footprint with additional facilities in the coming years.”

Robert Merritt also served as a conference speaker, delivering an educational session on substance use disorder treatment, behavioral health, and the stigma that continues to impact rural communities.

“We are extremely proud of Myrtle and the impact it continues to make throughout Tennessee,” said Seamus Lagan, Chief Executive Officer of FOXO. “This recognition affirms the essential role Myrtle plays in addressing behavioral health needs in rural communities and supports the business’ growth strategy of replicating Myrtle’s operating and care model throughout Tennessee.”

About FOXO Technologies Inc. (“FOXO”)

FOXO owns and operates four principal subsidiaries.

Rennova Community Health, Inc. owns and operates Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), a critical access designated (CAH) hospital in East Tennessee.

Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. Myrtle provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs.

Vector BioSource, Inc. is FOXO’s biologics and therapeutic services division, focused on the development and distribution of high-quality biological materials that support research, diagnostics, and emerging therapeutic applications.

FOXO Labs, Inc. is a biotechnology company dedicated to improving human health and life span through the development of cutting-edge technology and product solutions for various industries.

For more information about FOXO, visit www.foxotechnologies.com.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about FOXO’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. These factors include, but are not limited to the risk of changes in the competitive and highly regulated industries in which FOXO operates; variations in operating performance across competitors or changes in laws and regulations affecting FOXO’s business; the ability to implement FOXO’s business plans, forecasts, and other expectations; the ability to obtain financing; the risk that FOXO has a history of losses and may not achieve or maintain profitability in the future; the enforceability of FOXO’s intellectual property, including its patents and the potential infringement on the intellectual property rights of others; and the risk of downturns and a changing regulatory landscape in the highly competitive industries in which FOXO operates. The foregoing list of factors is not exhaustive. Readers should carefully consider the foregoing factors and the other risks and uncertainties discussed in FOXO’s most recent reports on Forms 10-K and 10-Q, particularly the “Risk Factors” sections of those reports, and in other documents FOXO has filed, or will file, with the Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and FOXO assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Sebastien Sainsbury
ssainsbury@foxotechnologies.com
(561) 485-0151


FAQ

What recognition did Myrtle Recovery Centers receive from the Rural Health Association of Tennessee on Dec. 9, 2025?

Myrtle received an RHA award at the Annual Conference Awards Luncheon for outstanding community engagement and service across Tennessee.

How many Tennessee counties has Myrtle Recovery Centers served as of December 2025?

Myrtle reported serving individuals from 63 of Tennessee’s 95 counties.

What operational status did Myrtle Recovery Centers report for most of 2025?

Myrtle said it was operating at capacity for most of 2025.

Does FOXO plan to expand Myrtle Recovery Centers after the RHA recognition?

Company leadership stated plans to increase capacity and replicate Myrtle’s operating and care model with additional facilities in coming years.

What topics did Myrtle CEO Robert Merritt present at the RHA Annual Conference?

Robert Merritt delivered an educational session on substance use disorder treatment, behavioral health, and rural stigma.
FOXO TECHNOLOGIES

OTC:FOXO

FOXO Rankings

FOXO Latest News

FOXO Latest SEC Filings

FOXO Stock Data

1.04M
1.75B
0.21%
0.25%
4.32%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States
WEST PALM BEACH